Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5783_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Contents
- •Contributors
- •1.2 How Is Critical Care Humanized?
- •References
- •2.1 Introduction
- •1.2.2 Communication
- •1.2.5 Post-ICU Syndrome
- •1.2.6 Humanized Infrastructure
- •1.2.7 End-of-Life Care
- •2.2 Which Patients Should Undergo ICP Monitoring?
- •2.5.2.3 CSF Drainage
- •2.5.2.4 Osmotherapy
- •2.5.2.5 Ventilation
- •2.5.2.6 CPP Augmentation
- •2.5.2.7 Metabolic Suppression
- •2.5.2.8 Pharmacologic Suppression
- •2.5.2.9 Temperature Modulation
- •2.5.2.10 Decompressive Craniectomy
- •2.7.1.1 Pressure Reactivity Index (PRx)
- •2.7.1.2 Multimodality Monitoring
- •2.8 Conclusion
- •Algorithm
- •References
- •3.1 Introduction
- •3.2 Intracerebral Hemorrhage (ICH)
- •3.3 ICH: Presenting Symptoms
- •3.5.1 Blood Hypertension
- •3.5.2 Other Risk Factors
- •3.6 ICH: Pathophysiology
- •3.7 ICH: Initial Management
- •3.7.1 Airway: Intubation
- •3.7.3 ICH: Imaging
- •3.7.4 ICH: Grading Scales
- •3.7.5 Fluid Management
- •3.7.6 Follow-Up Imaging
- •3.7.7 Blood Pressure Management
- •3.7.9 ICP Monitoring
- •3.7.10 Surgical Considerations
- •3.7.13 ICH: Venous Thromboembolism Prophylaxis
- •3.7.14 ICH: Seizure Management
- •3.8 ICH: Medical Complications
- •3.8.1 Glycemic Management
- •3.8.3 Disposition
- •3.9 Conclusion
- •Algorithm
- •Appendix: Direct Oral Anticoagulant Reversal
- •Reversal Strategies
- •References
- •4.1 Introduction
- •4.2.1 Hemodynamic Management
- •4.2.2 Hormonal Replacement Therapy
- •4.2.3 Respiratory Management
- •4.3 Cardiopulmonary Resuscitation (CPR)
- •4.4 Conclusion
- •Algorithm
- •References
- •5.1 Introduction
- •5.2.1 Vasoactive Agents
- •5.2.1.1 Vasodilators (Table 5.1)
- •Calcium Channel Blockers
- •Nimodipine
- •Nicardipine
- •Other Vasodilators
- •Magnesium
- •3-Hydroxy-3-Methyl-Glutaryl-CoA (HMG-CoA) Reductase Inhibitors (Statins)
- •Nitroprusside
- •Endothelin-1 Antagonists
- •Hydralazine
- •Phosphodiesterase Inhibitors
- •Papaverine
- •Norepinephrine
- •Epinephrine
- •Dopamine (DA)
- •Phenylephrine
- •Vasopressin
- •Neuromonitoring
- •5.2.2.1 Benzodiazepines
- •5.2.2.2 Barbiturates
- •5.2.2.3 Opioids
- •5.2.2.4 Anticonvulsant Medications
- •5.2.2.5 Other Sedatives/Anesthetics
- •5.2.3 Hemodynamic Agents
- •5.4 Conclusion
- •Algorithm
- •References
- •6.1 Introduction
- •6.2.3 Ultrasound Behaviour at Acoustic Boundaries
- •6.3 Pulse-Echo Principles (B-Mode Techniques)
- •6.4 Transducers
- •6.5 Artefacts
- •6.6 Doppler Principles
- •6.6.1 Pulsed Wave Doppler
- •6.6.2 Duplex Scanning
- •6.6.3 Colour Flow Imaging (CFI)
- •6.7.2 Flow Changes
- •6.7.3 Cerebrovascular Resistance
- •6.8 Transcranial Colour-Coded Duplex Sonography (TCCS)
- •6.9 Ultrasound Safety
- •6.10 Conclusion
- •References
- •7.1 Introduction
- •Mesencephalic Plane
- •7.2.1.2 Diencephalic Plane (Thalamic Plane)
- •6.6.4 Power Doppler Imaging (PDI)
- •6.7 Transcranial Doppler Ultrasound (TCD)
- •6.7.1 Velocity Measurement
- •7.2.1.3 Ventricular Plane (Cella Media)
- •7.2.1.4 Upper Pons Plane
- •7.2.1.5 Lower Pons Plane
- •7.2.2 Transforaminal Window
- •7.3.1.2 Anterior Circulation
- •Carotid System
- •Anterior Cerebral Artery
- •Anterior Communicating Antery
- •7.3.1.3 Posterior Circulation
- •Vertebrobasilar System
- •Posterior Communicating Artery
- •Posterior Cerebral Arteries
- •7.5 Cerebral Circulation: Anatomical Variations
- •7.5.1.1 Anterior Circulation
- •Most Common Variations [28]
- •7.5.1.2 Posterior Circulation
- •Most Common Variants [28]
- •7.6.1.1 Deep Middle Cerebral Vein (DMCV)
- •7.6.1.2 Basal Vein (of Rosenthal)
- •7.6.1.3 Great Cerebral Vein (of Galen)
- •7.6.2.1 Sphenoparietal Sinus
- •7.6.2.2 Superior Petrosal Sinus
- •7.6.2.3 Inferior Petrosal Sinus
- •7.6.2.4 Cavernous Sinus
- •7.6.2.5 Transverse Sinus
- •7.6.2.6 Straight Sinus
- •7.7 Conclusion
- •Algorithm
- •References
- •8.1 Introduction
- •8.2 Cerebral Blood Flow Measures
- •8.3 Transcranial Doppler (TCD/TCCS)
- •8.4.1 Cerebral Autoregulation (CA)
- •8.4.2 CO2 Vasoreactivity
- •8.6.2 TCD/TCCS: Use After Traumatic Brain Injury (TBI)
- •8.7 Conclusion
- •References
- •9.1 Introduction
- •9.3 TCD Hemodynamic Parameters: Variations by Sex
- •9.4 TCD Hemodynamic Parameters: Variations by Age
- •9.5 TCD Hemodynamic Parameters: Variations by Laterally
- •9.7 TCD Normal Values: Latin American Population Sample
- •9.8 TCD Hemodynamic Parameters: Altitude
- •9.10 Conclusion
- •References
- •10.1 Introduction
- •10.2 TCD/TCCS: Acoustic Windows
- •10.2.1.1 Technique
- •10.2.2.1 Technique
- •10.2.3.1 Technique
- •10.2.4.1 Technique
- •10.2.5.1 Technique
- •10.4.1 Decompressive Craniectomy
- •10.4.2 Patient’s Position
- •10.5 TCD/TCCS: Contrast-Enhanced
- •10.6 Conclusion
- •Algorithm
- •References
- •11.1 Introduction
- •11.2 Basic Methods
- •11.2.1 Flow Velocities
- •11.2.2 Pulsatility Index (PI)
- •11.3 Advanced Methods
- •11.3.2 TAU (Cerebrovascular Time Constant)
- •11.3.4 Autoregulation
- •11.4.1 Traumatic Brain Injury
- •11.4.2 Aneurysmal Subarachnoid Hemorrhage
- •11.4.3 Stroke
- •11.4.4 Other Clinical Scenarios
- •11.5 Conclusion
- •Algorithm
- •References
- •12.1 Introduction
- •12.2 TCD: Spectral Wave
- •12.4 TCD: Clinical Utility
- •12.6 TCD: Technique
- •12.6.2 Transtemporal Acoustic Window
- •12.6.2.1 Anterior Circulation
- •Middle Cerebral Artery (MCA)
- •12.6.2.2 Posterior Circulation
- •Posterior Cerebral Artery (PCA)
- •12.6.3 Submandibular Acoustic Window
- •12.6.3.1 Internal Carotid Artery (ICA—Extracranial Portion)
- •12.6.4 Transoccipital Acoustic Window
- •12.6.4.1 Posterior Circulation
- •12.6.5 Transorbital Acoustic Window
- •12.6.6.2 Pulsatility Index
- •12.7.1 High-Velocity Pattern
- •12.7.2 Low-Velocity Pattern
- •12.7.3 High Resistance Pattern
- •12.7.4 Cerebral Circulatory Arrest Pattern
- •12.8 TCD: Other Clinical Uses
- •12.8.1.1 Cerebral Vascular Reactivity
- •12.9 TCD: Limitations
- •12.10 Conclusion
- •Algorithm
- •References
- •13.1 Introduction
- •13.2 Acoustic Windows
- •13.3 2D-Guided TCD Monitoring
- •13.6 Conclusion
- •Algorithm
- •References
- •14.1 Introduction
- •14.2 TCCS: Anatomical Aspects
- •14.3.1 Anterior Circulation
- •14.3.1.1 Carotid System
- •14.3.2 Posterior Circulation
- •14.3.2.1 Vertebro-Basilar System
- •14.5 TCCS: Examiner Considerations
- •14.6 TCCS: Acoustic Windows
- •14.7 TCCS: Examination Protocol
- •14.7.1.1 Considerations
- •Doppler: (Convention)
- •14.7.2 Transtemporal Acoustic Window Examination (Coronal Planes)
- •14.7.3 Transoccipital (Transnuchal/Transforaminal) Acoustic Window Examination
- •14.7.4 Submandibular Acoustic Window Examination
- •14.7.5 Transorbital Acoustic Window Examination
- •14.7.6 Frontal Bone Window Examination
- •14.8 TCCS Protocol: Clinical Applications
- •14.9 TCCS Protocol: Hemodynamic Parameters
- •14.10 TCCS Protocol: Limitations
- •14.10.1 Limitations
- •14.10.1.1 Acoustic Windows
- •Transtemporal Acoustic Window
- •Suboccipital Acoustic Window
- •14.10.1.2 Middle-Line Shift Measurement
- •14.11 Conclusion
- •Algorithm
- •References
- •15.1 Introduction
- •15.2 Clinical Applications
- •15.2.1 Intracranial Stenosis
- •15.2.2 Cerebral Vasospasm
- •15.2.3 Cerebral Veins
- •15.3 Conclusion
- •References
- •16.1 Introduction
- •16.3.1 Autoregulation Index (ARI)
- •16.3.2 Mean Flow Velocity Index (Mx)
- •16.5 Conclusion
- •References
- •17.1 Introduction
- •17.2.1 Cerebrovascular Resistance (CVR)
- •17.2.2 Cerebral Autoregulation
- •17.2.4 Carbon Dioxide Reactivity
- •17.3.2 Collateral Flow
- •17.3.3 Elastic Reservoir (“Windkessel Effect”)
- •17.4 TCD: Waveform Interpretation
- •17.4.1 TCD Waveforms
- •17.5.1 Aneurysmal Subarachnoid Hemorrhage
- •17.5.2 Increased ICP
- •17.6 Conclusion
- •References
- •18.1 Introduction
- •18.3.1 Subarachnoid Hemorrhage (SAH)
- •18.3.1.1 Cerebral Autoregulation (CA)
- •18.3.1.2 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.1.3 Cerebral Blood Flow
- •18.3.1.4 Electrophysiology
- •Seizure Detection
- •18.3.1.5 Cerebral Metabolism
- •18.3.2 Intracerebral Hemorrhage (ICH)
- •18.3.2.1 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.2.3 Electrophysiology
- •18.3.3 Traumatic Brain Injury (TBI)
- •18.3.3.2 Cerebral Autoregulation
- •18.3.3.3 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.3.4 Cerebral Blood Flow
- •18.3.3.5 Electrophysiology
- •18.3.3.6 Cerebral Metabolism
- •18.3.4 Acute Ischemic Stroke (AIS)
- •18.3.4.1 Cerebral Blood Flow
- •18.3.4.2 Electrophysiology
- •18.3.5.1 Cerebral Blood Flow
- •18.4 Conclusion
- •References
- •19.1 Introduction
- •19.2 Cerebral Blood Haemodynamic Measurements
- •19.3 Cerebral Blood Flow (CBF): Physiology Principles
- •19.4 Vasoreactivity Determining: Methods
- •19.6 Technical Tips
- •19.7 Vasoreactivity: Clinical Importance
- •19.8 Conclusion
- •References
- •20.1 Introduction
- •20.5.4.1 Experimental Endotoxemia
- •20.6 Conclusion
- •Appendix
- •Methods
- •Group 1: Graphic Methods
- •“Beat-by-Beat Method”
- •Method Described by Aaslid
- •Group 2: Multiparameter or Impedance Methods [14]
- •References
- •21.1 Introduction
- •21.2.1 Brain Compliance
- •21.2.2 TCD/TCCS: Cerebral Hemodynamics
- •21.4 Pulsatility Index (PI): Intracranial Pressure (ICP)
- •21.5.1 Cardiovascular Factors
- •21.5.2 Cerebrovascular Factors
- •21.5.3 Cardiopulmonary Factors
- •21.5.4 Metabolism Factors
- •21.5.5 Vascular Factors
- •21.5.6 Other Factors
- •21.6 Conclusion
- •Algorithm
- •References
- •22.1 Introduction
- •22.2 Aneurysmal Subarachnoid Hemorrhage (aSAH)
- •22.3 Cerebral Vasospasm After aSAH
- •22.5.1 TCD/TCCS: Examination Protocol
- •22.5.1.1 Transtemporal Window
- •22.5.1.2 Orbital Window
- •22.5.1.3 Suboccipital/Transforaminal Window
- •22.5.1.4 Submandibular Window
- •22.7 Conclusion
- •Algorithm
- •References
- •23.1 Introduction
- •23.3.1 Premise
- •23.3.3 Limitations
- •23.4.1 Technical Requirements
- •23.4.3 Limitations
- •23.6 Future Directions
- •23.7 Conclusion
- •Algorithm
- •References
- •24.1 Introduction
- •24.2.1 Vasospasm
- •24.2.2 Vasospasm Diagnostic Criteria
- •24.3 TCD/TCCS: Cerebral Vasoreactivity
- •24.4 TCD/TCCS: Intraoperative Monitoring
- •24.7 Conclusion
- •References
- •25.1 Introduction
- •25.4 CAD: Diagnosis
- •25.6 Pupil: Ultrasound Examination
- •25.11 Conclusion
- •Algorithm
- •References
- •26.1 Introduction
- •26.2 Optimal Settings
- •26.2.1 Probe Types
- •26.2.2 Frequencies
- •26.2.3 Focus
- •26.2.4 Depth
- •26.2.5 Pulse Repetition Frequency (PRF)
- •26.2.6 Frame Rate
- •26.2.8 Freeze
- •26.2.9 Cine Loop
- •26.2.10 Smoothing (Interpolation), Interlacing, Correlation
- •26.2.11 Postprocessing
- •26.2.12 Resolution
- •26.2.13 Doppler-Technique
- •26.2.14 PW-Doppler (Pulsed-Wave Doppler)
- •26.2.15 Color Duplex
- •26.3 Indications
- •26.4.1.2 Morphological Differences
- •26.4.1.3 Flow Differences
- •26.4.1.4 Compression
- •26.5 B-Mode Examination
- •26.5.1 Dilation
- •26.5.2 Intima-Media Thickness (IMT)
- •26.5.3 Plaque Analysis
- •26.5.3.1 Location
- •26.5.3.3 Maximal Thickness
- •26.5.3.4 Surface
- •26.5.3.5 Echogenicity
- •26.5.4 B-Flow Imaging
- •26.6.1 Color Doppler Imaging (CDI)
- •26.6.2 Power Doppler Imaging (PDI)
- •26.7.1 Stenosis Measurement
- •26.7.1.1 Diameter Stenosis
- •26.7.1.2 Area Stenosis
- •26.7.1.3 Residual Luminal Diameter
- •26.7.2 Occlusion
- •26.7.3 Subtotal Stenosis: (>95% Stenosis)
- •26.7.4 Long Segment Stenosis
- •26.8 Doppler Spectrum
- •26.10 Contrast Enhanced Ultrasound (CEU)
- •26.11.1 Common Carotid Artery
- •26.11.2 Internal Carotid Artery
- •26.11.2.1 Stenosis
- •26.11.2.2 Dissection
- •26.11.2.3 Occlusion
- •26.11.2.4 Subtotal Occlusion: (95–99% Stenosis)
- •26.11.2.5 Multiple (Tandem) Stenosis
- •26.11.2.6 Long Segment Stenosis
- •26.11.3 External Carotid Artery (ECA)
- •26.11.3.1 Occlusion
- •26.13 Negative Report
- •26.14 Conclusion
- •Algorithm
- •References
- •27.1 Introduction
- •27.2 Anatomy: Vertebrobasilar System
- •27.3 Vertebrobasilar Circulation: Ultrasound Examination
- •27.4 TCD: Aneurysmal Subarachnoid Hemorrhage
- •27.4.1 Delayed Cerebral Ischemia
- •27.4.2 Vasospasm
- •27.5 TCD: Vertebrobasilar Dissection
- •27.6 TCD: Intracranial Stenosis
- •27.7 TCD: Microembolus Detection
- •27.9 Subclavian Steal Syndrome
- •27.10 TCD: Multimodal Monitoring
- •27.11 TCD: Traumatic Brain Injury
- •27.12 TCD: Brain Death Determination
- •27.13 Conclusion
- •References
- •28.1 Introduction
- •28.2 Cerebral Venous System: Anatomy
- •28.3 vTCCS: Ultrasound Investigation Technique
- •28.4 CVST: Venous Ultrasound Findings

8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
151
8.4.1 Cerebral Autoregulation (CA)
Cerebral autoregulation (CA) is dened as the ability of the cerebrovascular system
to maintain relative constant CBF despite changes in cerebral perfusion pressure
[17]. Thus, cerebral autoregulation is dened as a pressure phenomenon. The majority of autoregulatory control occurs at the level of the cerebral arterioles. Arterioles
will constrict and dilate in response to increases and decreases in cerebral perfusion
pressure, respectively, to maintain constant CBF between a cerebral perfusion pressure (CPP) of 50–150mmHg [18]. CBF outside of these ranges becomes dependent
upon the perfusion pressure. A signicant proportion of vascular resistance, however, is also mediated at the level of the small arteries. Alterations in sympathetic
tone of these pial arteries can shift the autoregulatory curve upward or downward
[19] (Fig.8.3).
The theoretical mechanisms by which CBF is maintained over a wide range of
perfusion pressures are quite extensive and beyond the scope of this review. Briey,
however, hypothesized mechanisms can be grouped into myogenic, metabolic, and
neurogenic categories. The myogenic theory postulates that smooth muscle cells of
the arteries and arterioles constrict or dilate in response to changes in transmural
pressure generated across the vessel wall [20]. This may be mediated through alterations in the position of the actin-myosin laments in these smooth muscles [21].
Passive
collapse
75
50
25
Cerebral Blood Flow (ml/100 g/min)
25
Vasodiatory
Cascade Zone
50 75 75
VASCULARCALIBER
Cerebral Perfusion Pressure (mm Hg)
Zone of Normal
Autoregulation
100125 150
Autoregulation
Breakthrough Zone
60
40
ICP (mm Hg)
20
Fig. 8.3 Dark line representing the autoregulatory curve. Note CBF matches CPP at the extremes
of the curve. The lighter line represents cerebral blood volume and the above vessels refer to the
state of patency at varying cerebral perfusion pressures. (Rose and Mayer [18])

152
The metabolic theory postulates that local changes in cerebral blood ow release a
variety of substances that both affect vessel diameter and couple ow with metabolism [22]. The neurogenic theory suggests that small intrinsic nerves may be responsible for changes in CBF [23].
E. M. Manno and F. Sorond
8.4.2 CO2 Vasoreactivity
Unlike cerebral autoregulation which is a pressure phenomenon, CO2 vasoreactivity
is a metabolic phenomenon. There is a direct increase in CBF with increasing PaCO2
[24, 25]. The response curve of CBF to Pa CO2 is sigmoidal with the CBF response
attening below 15–20mmHg and above 100mmHg (Fig.8.3). PaCO2 will freely
diffuse across the blood–brain barrier; however, changes in CBF are mediated through
changes in cerebral spinal uid (CSF) hydrogen ion concentration. These changes,
however, are short-lived as the choroid plexus of the brain will equilibrate and buffer
these changes over a few hours [26] returning CBF to its baseline level. Cerebrovascular
reserve is a terminology that is used to dene the amount of ow during maximal
arteriolar dilation. It is described as a percentage of maximal dilation [27].
8.5 TCD/TCCS: Assessment ofCerebral Autoregulation
andCO
Vasoreactivity
2
The assessment of cerebral autoregulation and CO2 vasoreactivity requires continuous monitoring of TCD/TCCS ow velocities during manipulations of blood pressure and CO2, respectively. Technically, this is achieved through the use of a head
holder that locks down the probes during insonation of bilateral ow velocities in
the vessels of interest.
Cerebral autoregulation can be evaluated under dynamic or static conditions.
Dynamic testing involves an induced drop in blood pressure or spontaneous blood
pressure oscillations during continuous TCD monitoring. Induced changes are often
performed during rapid deation of thigh blood pressure cuffs. The abrupt drop in
blood pressure leads to a mirrored drop in TCD ow velocities. In patients with poor
autoregulation, TCD ow velocities will parallel a slow return in blood pressure. In
patients with intact autoregulation, TCD/TCCS ow velocities will return to baseline immediately and will precede improvements in blood pressure. A similar type
of response called a transient hyperemic response to carotid compression can also
be employed [28]. In practice, however, these tests are rarely utilized in the intensive care unit.
Static autoregulation is measured using pharmacologic manipulation of blood
pressure during continuous TCD monitoring. It is calculated as a percentage change
in cerebrovascular reserve (CVR) / a percent change in CPP x 100. CVR is dened

8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
as CPP /mean TCD velocities Using this method, autoregulation is expressed as a
percentage with 100% signifying intact autoregulation [29, 30].
CO2 vasoreactivity can similarly be addressed while measuring continuous TCD
ow velocities during manipulation of PCO2. This can be achieved through breath
holding or changes in inspired pCO2. Acetazolamide can similarly be used, but concerns have been raised using this pharmacology since acetazolamide may directly
affect middle cerebral artery (MCA) diameter during testing and may complicate
the calculation of changes in CBF [31].
153
8.6 TCD/TCCS: Use intheNeurological Critical Care Unit
8.6.1 TCD/TCCS: Use inSubarachnoid Hemorrhage
TCD can be used in the neuro ICU for a variety of neurological processes. It is most
commonly used to detect the development of cerebral vasospasm after subarachnoid
hemorrhage. Cerebral vasospasm is a self-limited vasculopathy that develops
4–14days after subarachnoid hemorrhage. Pathologically, the basal cerebral arteries develop a T-cell inltrate, collagen remodeling, and smooth muscle proliferation
[32]. This can potentially lead to vessel narrowing and cerebral ischemia. Vasospasm
appears to be a reaction to the amount and location of subarachnoid blood as rst
described by Fisher [33] and later veried by Kistler [34].
Prior to the development of TCD, vasospasm could only be detected through the
use of cerebral angiography. Aaslid was able to demonstrate, however, a good correlation between MCA ow velocities and actual vessel luminal diameter as measured by angiography. Mean MCA ow velocities greater than 120cm/s represented
mild narrowing, while ow velocities greater than 200cm/sec represented severe
narrowing [1].
While TCD ow velocities can correlate with vessel narrowing, using TCD to
predict which patients will develop subsequent cerebral ischemia has been more
problematic. Initial studies suggested that absolute or rapid increases in ow velocities were indicative of impending neurological decits [35, 36]. However, subsequent studies could not reproduce these ndings [37].
The reasons for this discrepancy in ndings may be technical. TCD ow velocities need to be corrected for a variety of physiological parameters [38] but in practice rarely are. In an attempt to differentiate increased blood ow from vessel
narrowing, Lindegaard developed a ratio of ow velocities from the extracranial
carotid artery to the MCA.Elevated ow velocities in the MCA not matched in the
extracranial internal carotid artery (ICA) would suggest vessel narrowing, while
similar changes would suggest hyperemia [39]. Similar ratios have been developed
for the posterior circulation [40]. Disturbances in cerebral autoregulation after subarachnoid hemorrhage can lead to a misinterpretation of TCD ow velocities.
Manipulations of blood volume and blood pressure commonly employed for

154
E. M. Manno and F. Sorond
treatment of cerebral vasospasm can directly affect TCD ow velocities in patients
with disturbed autoregulation [30]. Measurements of cerebral vascular reserve in
patients with vessel narrowing may prove to be predictive of which patients are at
risk for developing ischemic decits [41].
Finally, the premise that vessel narrowing is the source of cerebral ischemia after
subarachnoid hemorrhage may be inaccurate. Recent speculations have suggested
that the hemoglobin released into the subarachnoid space binds spinal uid nitrous
oxide which is needed for vasomotor coupling of metabolism to CBF [42].
Rabinstein reported that most cerebral infarcts after subarachnoid hemorrhage
occurred in vascular territories unaffected by vessel narrowing [43]. Similarly, the
results of the Conscious-2 trial a randomized study of an endothelin receptor antagonist reported signicant improvement in vessel narrowing after subarachnoid hemorrhage with no effect on ischemic decits or outcome [44].
8.6.2 TCD/TCCS: Use After Traumatic Brain Injury (TBI)
TCD/TCCS has been used to facilitate management in the intensive care unit [45].
TCD use after TBI can be utilized to estimate intracranial pressure (ICP), determine
the status of cerebral autoregulation, and determine if cerebral vasospasm.
Changes in TCD waveforms have been documented with increases in ICP.Loss
of distal compliance leads to an increased pulsatility index. Continued increases
lead to loss of diastolic ow velocities. At extreme levels, systolic spikes and loss of
TCD waveforms are noted [46]. Pulsatility indexes have been correlated with ICP
in a variety of cerebral conditions; however, attempts to dene ICP based on TCD/
TCCS waveform analysis have fallen short [47].
While TCD/TCCS waveforms as yet cannot be used to replace ICP, monitoring
increases in pulsatility indexes can be used to potentially identify expanding lesions,
focal or global increases in ICP, and decreases in CPP.Continuous TCD monitoring
has noted an increase in pulsatility indexes in head trauma patients at their CPP
dropped below 70mmHg, thus potentially providing a warning for inadequate perfusion [48]. Flow velocities below 35cm/sec suggesting decreased CBF after head
trauma have been associated with poor outcomes [48, 49]. Similarly, loss of cerebral
autoregulation is common after head trauma and has been associated with worse
outcomes. Identifying these disturbances early in the post-traumatic course may
allow for individualized therapies [50, 51].
Traumatic subarachnoid hemorrhage is common, and cerebral vasospasm can
develop in similar patterns as detected after aneurysmal subarachnoid hemorrhage.
Cerebral vasospasm after head trauma has been identied as a predictor of poor
outcome [52], and medical maneuvers designed to increase CBF can potentially be
employed. Interestingly, posterior circulation vasospasm is more common after
traumatic subarachnoid hemorrhage [53].

8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
155
8.6.3 TCD/TCCS: Conrmation ofBrain Death
TCD can be utilized as a conrmatory test to assess for the absence of CBF in
patients that have met criteria for brain death. The portability of TCD allows for the
assessment of hemodynamically unstable patients that may not tolerate transfer outside of the intensive care unit. TCD use as a conrmation test has been reported to
shorten the time of diagnosis.
Several patterns of waveforms have been described to indicate the absence of
effective perfusion. These include small systolic spikes, oscillating ow, and loss of
signal which had previously been isolated [54]. If vessels have not been previously
insonated, the absence of signal cannot be utilized since in about 10% of patients’
vessels cannot be insonated through the temporal bone. Sensitivity increases with
the number of vessels which can be isolated. A lower false-positive rate has been
reported when using a transorbital approach [55].
A recent meta-analysis conrmed the diagnostic accuracy or TCD conrmation
of brain death, and most countries accept TCD as an ancillary test to conrm brain
death [56]. Consensus guidelines for the determination of circulatory arrest have
been proposed by the World Federation of Neurology [57]. Despite this, Canada,
Australia, and New Zealand prefer other methods for conrmation [58].
8.6.4 TCD/TCCS: Use inIntracerebral Hemorrhage
TCD use after intracerebral hemorrhage traditionally had limited value. Poorer outcomes have been noted in patients with disturbed cerebral autoregulation and CO2
vasoreactivity [59]. Differences in the middle cerebral artery pulsatility indexes
may suggest side-to-side differentials in ICP.
Newer sonographic techniques have been used in the ICU to evaluate intracerebral hemorrhages. Transcranial color-coded sonography has identied spontaneous
hemorrhages [60]. Transcranial duplex sonography has identied midline shift after
intracerebral hemorrhage and has been utilized to predict outcome after hemorrhage
[61, 62].
8.6.5 TCD/TCCS: Other Uses intheIntensive Care Unit
A variety of information can be gathered during routine TCD evaluation. Evidence
for midline shift or a different location of a vessel previously insonated can suggest
the development of a mass lesion. High-intensity transient signals (HITS) suggest
recurrent emboli which can be detected during transient ischemic attack evaluation

156
E. M. Manno and F. Sorond
or post-carotid endarterectomy [63]. Reversal or patency of vessels can be evaluated
using TCD after bypass operations. Changes in vascular resistance can signify a
local mass lesion or decreased perfusion. All may point to the need for additional
imaging. More recently, increased continuous MCA ow velocities were noted during episodes of non-convulsive status epilepticus [64].
8.7 Conclusion
TCD/TCCS has gained increasing acceptance and use due to its many advantages of
ease of use and access, cost, portability, and reliability. By measuring ow velocities, both cerebral and CO2 vasoreactivity can be assessed providing valuable information to the neurological status of the patient. TCD, while unable to predict with
condence which patients will develop ischemic complications after subarachnoid
hemorrhage, is quite useful in identifying that cerebral vasospasm is developing.
Subsequently, this can focus neurological assessments and treatments. It is a useful
tool in several circumstances for conrming brain death in the hemodynamically
unstable patient. Newer sonographic techniques have been developed that will offer
promising new insights into both the pathogenesis and prognosis of a number of
acute neurological conditions.
References
1. Aaslid R, Markwalder T-M, Nornes H.Noninvasive transcranial Doppler ultrasound recording
of ow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769–74.
2. Fick A.Ueber die Messung des Blutquantums in den Herzventrikeln. Sitz ber Physik-Med Ges
Wurzburg. 1870;2:16–28.
3. Kety SS, Schmidt CF.The determination of cerebral blood ow in man by the use of nitrous
oxide in low concentrations. Am J Phys. 1945;143:53–66.
4. Manno EM, Koroshetz WJ. Cerebral blood ow. Chapter 5. In: Babikian VL, Wechsler LR,
editors. Transcranial Doppler ultrasonography. 2nd ed. Boston: Butterworth Heinmann; 1999.
p.67–87.
5. Aaslid R.Development of the principles of transcranial Doppler ultrasound. In: Aaslid R,
Newell DE, editors. Transcranial Doppler. NewYork: Raven Press; 1992. p.1–8.
6. Saver JL, Feldmann E.Basic transcranial Doppler examinations. In: Babikian VL, Wechsler
LR, editors. Transcranial Doppler ultrasonography. Mosby-Year Book: St Louis; 1993.
p.11–28.
7. Manno EM.Transcranial Doppler ultrasonography in the neurocritical care unit. In: Diringer
MN, editor. Critical care clinics, vol. 13. Philadelphia: W.B.Saunders; 1997. p.79–104.
8. Sorteberg W.Cerebral artery blood velocity and cerebral blood ow. In: Newell DW, Aaslid R,
editors. Transcranial Doppler. NewYork: Raven; 1992. p.57–66.
9. Sorteberg W, Lindegaard KF, Rootwell K, etal. Blood velocity and regional blood ow in
dened cerebral artery systems. Acta Neurochir. 1989;97:47–52.
10. Schoning M, Walter J, Scheel P.Estimation of cerebral blood ow through color duplex sonog-
raphy of the carotid and vertebral arteries in healthy adults. Stroke. 1994;25:17–22.

8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
11. Kirkham FJ, Padayachee TS, Parsons S, etal. Transcranial measurement of blood velocities
in the basal cerebral arteries using pulsed Doppler ultrasound: velocity as an index of ow.
Ultrasound Med Biol. 1986;12:15–21.
12. Dahl A, Russell D, Nyberg-Hansen R, etal. Simultaneous assessment of vasoreactivity using
transcranial Doppler ultrasound and cerebral blood ow in healthy subjects. J Cereb Blood
Flow Metab. 1994;14:974–81.
13. Sorteberg W, Lindegaard KF, Rootwell K, etal. Effect of acetazolamide on cerebral artery blood
velocity and regional cerebral blood ow in normal subjects. Acta Neurochir. 1989;97:47–52.
14. Naylor AR, Merrick MV, Slattery JM, etal. Parametric imaging of cerebrovascular reserve.
Eur J Nucl Med. 1991;18:259–64.
15. Kofke WA, Brauer P, Policare R, etal. Middle cerebral artery blood ow velocity and stable
xenon-enhanced computed blood ow during test balloon occlusion of the internal carotid
artery. Stroke. 1995;26:1603–6.
16. Hartmann A, Ries F, Tsuda Y, et al. Correlation of regional cerebral blood ow and blood
ow velocity in normal volunteers and patients with cerebro-vascular disease. Neurochirgia
(Stuttg). 1991;34:6–13.
17. Manno EM, Rabinstein AA.Central nervous system. Chapter 43. In: Gabriella A, Layton AJ,
Yu M, editors. Civetta, Taylor, and Kirby’s critical care. 4th ed. Philadelphia: Wolters Kluver
Lippincott Williams and Wilkins; 2009. p.649–65.
18. Rose JC, Mayer SA.Optimizing blood pressure in neurological emergencies. Neurocrit Care.
2004;1:287–99.
19. Edvisson L.Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine
receptors, and their effects on cerebral blood ow. Acta Physiol Scand Suppl. 1975;427:1.
20. Kontos HA, Wei EP, Navari RM, etal. Responses of cerebral arteries and arterioles to acute
hypotension and hypertension. Am J Physiol Heart Circ Physiol. 1978;234:H371.
21. Folkow B.Description of the myogenic hypothesis. Circ Res. 1964;15:279–87.
22. Chillon JM, Baumbach JL.Autoregulation: arterial and intracranial pressure. In: Edvisson L,
Krause DN, editors. Cerebral blood ow and metabolism. 2nd ed. Philadelphia: Lippincott
Williams and Wilkens; 2002. p.395–412.
23. Lou HC, Edvission L, MacKenzie ET.The concept of coupling blood ow to brain function:
revision required? Ann Neurol. 1987;22:289.
24. Ginsberg MD.Cerebral circulation: its regulation, pharmacology, and pathophysiology. In:
Asbury AK, McKhann GM, McDonald WI, editors. Diseases of the nervous system clinical
neurobiology. Philadelphia: Saunders; 1992. p.989–1001.
25. Harper AM, Glass HI.Effect of alterations in the arterial carbon dioxide tension on the blood
ow through the cerebral cortex at normal and low arterial pressures. J Neurol Neurosurg
Psychiatry. 1965;28:449–52.
26. Ropper AH.Treatment of intracranial hypertension. In: Ropper AH, editor. Neurological and
neurosurgical intensive care. 3rd ed. NewYork: Raven Press; 1993. p.29–52.
27. Ringelstein EB, Otis SM. Physiological testing of vasomotor reserve. Chapter 8. In: Newell
DW, Aaslid R, editors. Transcranial Doppler. NewYork: Raven; 1992. p.83–100.
28. Aaslid R.Cerebral Hemodynamics chapter 5. In: Newell DW, Aaslid R, editors. Transcranial
Doppler. NewYork: Raven; 1992. p.49–55.
29. Tiecks FP, Lam AM, Aaslid R, Newell DW.Comparison of static and dynamic autoregulation
measurements. Stroke. 1995;26:1014–9.
30. Manno EM, Gress DR, Schwamm LH, et al. Effects of induced hypertension on transcra-
nial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke.
1998;29:422–8.
31. Ringelstein EB, van Eyck S, Mertens I.Evaluation of cerebral vasomotor reactivity by vari-
ous vasodilating stimuli: comparison of CO2 with acetazolamide. J Cereb Blood Flow Metab.
1992;12:162–8.
32. Tresser SJ, Selmon WR, Ratcheson RA.Pathophysiological alterations following aneurysm
rupture. Concepts Neurosurg. 1994;6:23–45.
157

158
33. Fisher CM, Kistler JP, Davis JM.Relation of cerebral vasospasm to subarachnoid hemorrhage
visualized on computed tomographic scanning. Neurosurgery. 1980;6:1–9.
34. Kistler JP, Crowell RM, Davis KR, etal. The relation of cerebral vasospasm to the extent
and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology.
1983;33:424–36.
35. Seckhar LN, Wechsler LR, Yonas H, etal. Value of transcranial Doppler examination in the diag-
nosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1988;22:813–21.
36. Sloan MA, Rigamonti D, Rothman M, etal. Sensitivity and specicity of transcranial Doppler
ultrasound in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology.
1989;39:1514–8.
37. Laumer R, Steinmeier R, Gonner F, et al. Cerebral hemodynamics in subarachnoid hemor-
rhage evaluated by transcranial Doppler ultrasonography. Part 1: reliability of ow velocities
in clinical management. Neurosurgery. 1993;33:1–9.
38. Brass LM, Pavlakis SG, DeVivo D, etal. Transcranial Doppler measurements of the middle
cerebral artery: effect of hematocrit. Stroke. 1988;19:1466–9.
39. Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm after subarachnoid hemor-
rhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien).
1988;42:81–4.
40. Soustiel JF, Shik V, Schreiber R, etal. Basilar vasospasm diagnosis: investigation of a modied
“Lindegaard index” based on imaging studies and blood velocity measurements of the basilar
artery. Stroke. 2002;33:72–7.
41. Hassler W, Chiof F.CO2 reactivity of cerebral vasospasm after aneursysmal subarachnoid
hemorrhage. Acta Neurochir. 1989;98:167–75.
42. Siuta M, Zuckerman SL, Mocco J.Nitric oxide in cerebral vasospasm. Theories measurement
and treatment. Neurology Research International; 2013;2013:11. Article ID 972417.
43. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF.Patterns of cerebral infarction in aneu-
rysmal subarachnoid hemorrhage. Stroke. 2005;36:992–7.
44. MacDonald RL, Higashida RT, Keller E, etal. Clazosentan, an endothelian receptor antagonist
in patients with subarachnoid hemorrhage undergoing surgical clipping: a randomized double
blinded placebo controlled phase 3 trial (conscious −2). Lancet Neurol. 2011;10:618–25.
45. White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive
Care Med. 2006;32:981–94.
46. Hassler W, Steinmetz H, Gawloswski J.Transcranial Doppler ultrasongraphy in raised intra-
cranial pressure and in circulatory arrest. J Neurosurg. 1988;68:745–51.
47. Klingelhofer J, Conrad B, Benecke R, etal. Evaluation of intracranial pressure from transcra-
nial Doppler studies in cerebral disease. J Neurol. 1988;235:159–62.
48. Chan K-H, Miller JD, Dearden NM. Intracranial blood ow velocity after head injury: rela-
tionship to severity of injury, time, neurological status, and outcome. J Neurol Neurosurg
Psychiatry. 1992;55:787–91.
49. Van Santbrink H, Schouten JW, Steyerberg EW, etal. Serial transcranial Doppler measure-
ments in traumatic brain injury with special focus on the early posttraumatic period. Acta
Neurochir. 2002;144:1141–9.
50. Vavilala MS, Lee LA, Boddu K, etal. Cerebral autoregulation in pediatric traumatic brain
injury. Pediatr Crit Care Med. 2004;5:257–63.
51. Schmidt EA, Czosnyka M, Steiner LA, etal. Asymmetry of pressure autoregulation after trau-
matic brain injury. J Neurosurg. 2003;99:991–8.
52. Compton JS, Teddy PJ.Cerebral arterial vasospasm following severe head injury: a transcra-
nial Doppler study. Br J Neurosurg. 1987;1:435–9.
53. Martin NA, Doberstein C, Zane C, et al. Posttraumatic cerebral arterial spasm: transcra-
nial Doppler ultrasound, cerebral blood ow, and angiographic ndings. J Neurosurg.
1992;77:575–83.
54. Azevedo E, Teixeira J, Neves JC, Vaz R.Transcranial Doppler and brain death. Transplant
Proc. 2000;32:2579–81.
E. M. Manno and F. Sorond

8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
55. Dominguez-Roldan JM, Jimenez-Gonzalez PI, Garcia-Alfaro C, etal. Diagnosis of brain death
by transcranial Doppler sonography: solutions for cases of difcult sonic windows. Transplant
Proc. 2004;36:2896–7.
56. Chang JJ, Tsivgoulis G, Katsanos AH, etal. Diagnostic accuracy of transcranial Doppler for
brain death conrmation: systemic review and meta-analysis. AJNR. 2016;37:408–14.
57. Ducrocq X, Hassler W, Moritake K, etal. Consensus opinion on diagnosis of cerebral circula-
tory arrest using Doppler-sonography: task force group on cerebral death of the neurosonology
research group of the World Federation of Neurology. J Neurol Sci. 1998;159:145–50.
58. Young GB, Shemie SD, Doig J, Teitelbaum JT.Brief review: the role of ancillary tests in the
neurological determination of death. Can J Anesth. 2006;53:620–7.
59. Klingelhofer J, Sander D.Doppler CO2 test as an indicator of cerebral vasoreactivity and
prognosis in severe intracerebral hemorrhage. Stroke. 1992;23:962–6.
60. Kukulska-Pawluczul B, Ksiazkiewicz B, Nowaczewska M. Imaging of spontaneous intra-
cerebralhemorrhages by means of transcranial colr-coded sonography. Europ J Radiol.
2012;81:1253–8.
61. Kiphuth IC, Huttmer HB, Breuer L, etal. Songraphic monitoring of midline shift predicts
outcome after intracerebral hemorrhage. Cerebrovascular Dis. 2012;34:297–304.
62. Camps-Renom P, Granell JME, Prats-Sanchez L, etal. Transcranial duplex sonography pre-
dicts outcome following intracerebral hemorrhage. AJNR. 2017;38:1543–9.
63. Spencer MP, Thomas GI, Nicholls SC, Sauvage LR.Detection of middle cerebral emboli dur-
ing carotid endarterectomy using transcranial doppler ultrasound. Stroke. 1990;21:415–23.
64. Merceron S, Geeraerts T, Montlahuc C, etal. Assessment of cerebral blood ow in nonconvul-
sive status epilepticus in comatose patients: a pathophysiological transcranial Doppler study.
Seizure. 2014;23:284–9.
159

Part III
Neurosonology: Neurocritical Care Patient
Соседние файлы в папке Библиотека им академика М.И. Перельмана
